HitGen offers comprehensive drug discovery services (target validation, hit identification, hit-to-lead, lead optimization, preclinical studies, IND filing and clinical development) centered around our world-leading DNA-encoded compound library (DEL) technologies and Fragment-based drug discovery (FBDD) to our customers. We have flexible business models, including single capability-based Fee For Service (FFS), Full-time Equivalent (FTE), Integrated Drug Discovery Service (IDDS), risk-sharing projects and collaborative vertures.
川公网安备 51012202000492号
We use cookies to provide a better web experience.
By using our site, you acknowledge our use of cookies and please read our Cookie Notice for
More information
